Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Analyze global market entry opportunities
  • Formulary management

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Chlorothiazide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for chlorothiazide?

Chlorothiazide is the generic ingredient in eleven branded drugs marketed by Mylan, Watson Labs, Hikma Intl Pharms, Lederle, Oak Pharms Akorn, Abc Holding, Salix Pharms, Sandoz, Sun Pharma Global, Luitpold, Sagent Pharms, Mylan Institutional, Fresenius Kabi Usa, Merck, Par Pharm, and Hikma Pharms Llc, and is included in thirty NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are forty-one drug master file entries for chlorothiazide. Seven suppliers are listed for this compound.

Summary for Generic Name: chlorothiazide

Drug Master File Entries: see list41
Suppliers / Packagers: see list7
Bulk Api Vendors: see list52
Clinical Trials: see list3
Patent Applications: see list7,143
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:chlorothiazide at DailyMed

Pharmacology for Ingredient: chlorothiazide

Drug ClassThiazide Diuretic
Physiological EffectIncreased Diuresis
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
TABLET;ORAL084388-001Approved Prior to Jan 1, 1982RXNoYes► Subscribe► Subscribe
Hikma Pharms Llc
chlorothiazide; reserpine
TABLET;ORAL088557-001Dec 22, 1983DISCNNoNo► Subscribe► Subscribe
chlorothiazide sodium
INJECTABLE;INJECTION202561-001Apr 22, 2013RXNoNo► Subscribe► Subscribe
chlorothiazide; reserpine
TABLET;ORAL011635-003Aug 26, 1987DISCNNoNo► Subscribe► Subscribe
Salix Pharms
SUSPENSION;ORAL011870-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.